Oral Nicotinamide Reduces Actinic Keratoses in Phase II Double-Blinded Randomized Controlled Trials
Authors:
- 1 May 2012
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 132 (5) , 1497-1500
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Nicotinamide Prevents Ultraviolet Radiation‐induced Cellular Energy LossPhotochemistry and Photobiology, 2010
- Randomized, double-blinded, placebo controlled study to assess the effect of topical 1% nicotinamide on actinic keratosesBritish Journal of Dermatology, 2010
- Photoprotective effects of nicotinamidePhotochemical & Photobiological Sciences, 2010
- Actinic keratosesCancer, 2009
- Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humansCarcinogenesis, 2008
- UV Radiation-Induced Immunosuppression Is Greater in Men and Prevented by Topical NicotinamideJournal of Investigative Dermatology, 2008
- A simple sample size formula for analysis of covariance in randomized clinical trialsJournal of Clinical Epidemiology, 2007
- Epidemiology of solar keratosesBritish Journal of Dermatology, 2006
- The Therapeutic Potential of Poly(ADP-Ribose) Polymerase InhibitorsPharmacological Reviews, 2002
- Incidence and determinants of skin cancer in a high‐risk australian populationInternational Journal of Cancer, 1990